Antidyslipidemia Pharmacotherapy in Chronic Kidney Disease: A Systematic Review and Bayesian Network Meta-Analysis

• Ngā kaituhi matua: Guangzhi Liao (Author), Xiangpeng Wang (Author), Yiming Li (Author), Xuefeng Chen (Author), Ke Huang (Author), Lin Bai (Author), Yuyang Ye (Author), Yong Peng (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2022-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background and Aims: The benefits and safety of antidyslipidemia pharmacotherapy in patients with chronic kidney disease were not well defined so the latest evidence was summarized by this work. Methods: This systematic review and Bayesian network meta-analysis (NMA) included searches of PubMed, Emb...